GBD 2019 | Collaborating in England
Published October 21, 2020
Professor John Newton, Director of Health Improvement at Public Health England, describes how the agency regularly provides insights and ideas to the annual Global Burden of Disease Study, and uses information from the study to influence health policy.
"We've had some great successes in this country with the GBD study," says Professor Newton.
One of the great successes of our collaboration with Public Health England was the use of Global Burden of Disease Study data to inform the National Health Service of England's 10-year strategy.
The GBD is a powerful tool for health researchers, policymakers, economists, epidemiologists, and many others. Explore GBD 2019: www.healthdata.org/gbd
Transcription: Hello everybody. My name is John Newton, I'm Director of Health Improvement at Public Health England. I'm really looking forward to the new 2019 estimates of the Global Burden of Disease. With been collaborating with IHME on the GBD since 2013, and its been an incredibly productive collaboration for us. We've also found it to be a genuine dialogue with IHME very happy to hear our ideas on the use of new data or on the application of GBD results in policy and practice. We've had some great successes in this country with GBD. We've reported the results and we've also influenced policy. We're particularly pleased with the work that IHME did on our behalf on sub-national estimates in England, and on demonstrating health inequalities in sub-national geographies. One of the great strengths of GBD is it's continually developing both technically and in the scope, and therefore, the application. So we look forward to using these new results. It's been incredibly helpful here in England as I'm sure it is in many other countries across the world. Thank you.